144 related articles for article (PubMed ID: 35241570)
1. A Case of Recurrent Metastatic Parotid Acinic Cell Carcinoma Responsive to Pembrolizumab.
Yamashita G; Okamoto I; Shimizu A; Tokashiki K; Okada T; Sato H; Tsukahara K
In Vivo; 2022; 36(2):1047-1051. PubMed ID: 35241570
[TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW; Soulières D; Le Tourneau C; Dinis J; Licitra L; Ahn MJ; Soria A; Machiels JP; Mach N; Mehra R; Burtness B; Zhang P; Cheng J; Swaby RF; Harrington KJ;
Lancet; 2019 Jan; 393(10167):156-167. PubMed ID: 30509740
[TBL] [Abstract][Full Text] [Related]
3. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Seiwert TY; Burtness B; Mehra R; Weiss J; Berger R; Eder JP; Heath K; McClanahan T; Lunceford J; Gause C; Cheng JD; Chow LQ
Lancet Oncol; 2016 Jul; 17(7):956-965. PubMed ID: 27247226
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
Harrington KJ; Soulières D; Le Tourneau C; Dinis J; Licitra LF; Ahn MJ; Soria A; Machiels JH; Mach N; Mehra R; Burtness B; Ellison MC; Cheng JD; Chirovsky DR; Swaby RF; Cohen EEW
J Natl Cancer Inst; 2021 Feb; 113(2):171-181. PubMed ID: 32407532
[TBL] [Abstract][Full Text] [Related]
5. [Distant metastases on acinic cell carcinoma of the parotid gland after 12 years symptom-free interval].
Smukalla K; Kalinski T; Motsch C
Laryngorhinootologie; 2006 Aug; 85(8):586-8. PubMed ID: 16883494
[TBL] [Abstract][Full Text] [Related]
6. Acinic cell carcinoma of parotid gland with cavernous sinus metastasis: A case report.
Francis Thottian AG; Gandhi AK; Ramateke PP; Gogia A
J Cancer Res Ther; 2018; 14(6):1428-1430. PubMed ID: 30488869
[TBL] [Abstract][Full Text] [Related]
7. Acinic cell carcinoma of the parotid gland in children: a case report and literature review.
Michail P; Karavokyros I; Pikoulis E; Arvelakis A; Charminis G; Michail O; Theodoros D
West Indian Med J; 2008 Jan; 57(1):70-2. PubMed ID: 19565943
[TBL] [Abstract][Full Text] [Related]
8. A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
Rodriguez CP; Wu QV; Voutsinas J; Fromm JR; Jiang X; Pillarisetty VG; Lee SM; Santana-Davila R; Goulart B; Baik CS; Chow LQM; Eaton K; Martins R
Clin Cancer Res; 2020 Feb; 26(4):837-845. PubMed ID: 31796519
[TBL] [Abstract][Full Text] [Related]
9. Acinic cell carcinoma of the parotid gland presenting as an external auditory canal mass.
Prasad M; Kraus DH
Head Neck; 2004 Jan; 26(1):85-8. PubMed ID: 14724911
[TBL] [Abstract][Full Text] [Related]
10. Late recurrence of acinic cell carcinoma of the parotid gland.
Miki H; Masuda E; Ohata S; Komaki K; Hirokawa M; Uehara H; Asano H; Monden Y
J Med Invest; 1999 Aug; 46(3-4):213-6. PubMed ID: 10687318
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.
Chow LQM; Haddad R; Gupta S; Mahipal A; Mehra R; Tahara M; Berger R; Eder JP; Burtness B; Lee SH; Keam B; Kang H; Muro K; Weiss J; Geva R; Lin CC; Chung HC; Meister A; Dolled-Filhart M; Pathiraja K; Cheng JD; Seiwert TY
J Clin Oncol; 2016 Nov; 34(32):3838-3845. PubMed ID: 27646946
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population.
Chen WC; Chu PY; Lee YT; Lu WB; Liu CY; Chang PM; Yang MH
Medicine (Baltimore); 2017 Dec; 96(52):e9519. PubMed ID: 29384959
[TBL] [Abstract][Full Text] [Related]
13. Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder.
Osumo B; Radzevich J; Nashed N; Ustwani O; Slotman G
Am Surg; 2022 Apr; 88(4):799-801. PubMed ID: 34747234
[TBL] [Abstract][Full Text] [Related]
14. Acinic cell carcinoma of the parotid gland in a child.
Sato T; Kamata SE; Kawabata K; Nigauri T; Mitani H; Beppu T; Sato M
Pediatr Surg Int; 2005 May; 21(5):377-80. PubMed ID: 15806422
[TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
Sacco AG; Chen R; Worden FP; Wong DJL; Adkins D; Swiecicki P; Chai-Ho W; Oppelt P; Ghosh D; Bykowski J; Molinolo A; Pittman E; Estrada MV; Gold K; Daniels G; Lippman SM; Natsuhara A; Messer K; Cohen EEW
Lancet Oncol; 2021 Jun; 22(6):883-892. PubMed ID: 33989559
[TBL] [Abstract][Full Text] [Related]
16. FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy.
Larkins E; Blumenthal GM; Yuan W; He K; Sridhara R; Subramaniam S; Zhao H; Liu C; Yu J; Goldberg KB; McKee AE; Keegan P; Pazdur R
Oncologist; 2017 Jul; 22(7):873-878. PubMed ID: 28533473
[TBL] [Abstract][Full Text] [Related]
17. Metastatic hepatocellular carcinoma mimicking acinic cell carcinoma of the parotid gland: a case report.
Moore FR; Bergman S; Geisinger KR
Acta Cytol; 2010; 54(5 Suppl):889-92. PubMed ID: 21053563
[TBL] [Abstract][Full Text] [Related]
18. Familial bilateral acinic cell carcinoma of the parotid synchronous with pituitary adenoma: case report.
Delides A; Velegrakis G; Kontogeorgos G; Karagianni E; Nakas D; Helidonis E
Head Neck; 2005 Sep; 27(9):825-8. PubMed ID: 15920750
[TBL] [Abstract][Full Text] [Related]
19. Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study.
Harrington KJ; Kong A; Mach N; Chesney JA; Fernandez BC; Rischin D; Cohen EEW; Radcliffe HS; Gumuscu B; Cheng J; Snyder W; Siu LL
Clin Cancer Res; 2020 Oct; 26(19):5153-5161. PubMed ID: 32669371
[TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab vs the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Lang Y; Dong D; Wu B
Clin Drug Investig; 2020 Dec; 40(12):1137-1146. PubMed ID: 33095408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
